Fig. 1From: Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysisForest plots of aOR showing clinical cure rate (a), microbiological failure rate (b), resistance occurrence (c), and mortality rate (d) in critically ill patients attaining aggressive vs. conservative PK/PD targets of beta-lactamsBack to article page